General - Therapies
Device General - Therapies_EP
General payments
$3,426,326
Research payments
$173,425
Through program year 2025, $3,426,326 in general payments and $173,425 in research payments were reported against General - Therapies (General - Therapies_EP).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,032,561 | 1,791 |
| 2025 | Research | $15,090 | 8 |
| 2024 | Research | $158,336 | 59 |
| 2022 | General | $393,765 | 401 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,192 general · 67 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.